ReviewClinical and experimental medicine2023
Evaluation of Bruton tyrosine kinase inhibitors monotherapy and combination therapy in lymphocytic leukemia.
Xiangxing Liu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this paperpooled itcites it